Differential sensitivity of pancreatic and colon cancer to cyclosporine and α-difluoromethylornithine in vivo

Rami Saydjari, Courtney Townsend, Samuel C. Barranco, James C. Thompson

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We have previously reported that the in vitro growth of MC-26 mouse colon cancer and H2T hamster pancreatic cancer cells are inhibited by cyclosporine (CsA) and α-difluoromethylornithine (DFMO). The present study was designed to investigate the effects of these two drugs on the two experimental tumors (MC-26 and H2T) growing in vivo. Forty-eight male Balb/c mice or Syrian golden hamsters were inoculated with MC-26 (250,000) or H2T (500,000) cells, respectively, and then were randomized into four groups of 12 each: group I was control; group II received CsA; group III received DFMO; group IV received a combination of CsA and DFMO. MC-26 tumors were significantly more sensitive than H2T tumors to the effects of CsA and DFMO. MC-26 tumor growth and tumor weight, as well as the tumor content of DNA, RNA, and protein were all significantly more reduced by CsA and DFMO than were the H2T tumors. Our present study shows that both CsA and DFMO are potent inhibitors of MC-26 colon carcinoma growth in vivo, though DFMO is more than twice as effective as CsA. DFMO also produced greater reductions in the tumor content of DNA, RNA, and protein than did CsA. DFMO significantly decreased the concentrations of polyamines in both H2T and MC-26 tumors; the MC-26 tumors were affected to a greater degree.

Original languageEnglish (US)
Pages (from-to)265-272
Number of pages8
JournalInvestigational New Drugs
Volume6
Issue number4
DOIs
StatePublished - Dec 1988
Externally publishedYes

Fingerprint

Eflornithine
Pancreatic Neoplasms
Colonic Neoplasms
Cyclosporine
Neoplasms
Growth
RNA
DNA
Mesocricetus
Polyamines
Tumor Burden
Cricetinae
Colon
Proteins
Carcinoma

Keywords

  • colon cancer
  • cyclosporine
  • DFMO
  • pancreatic cancer
  • polyamines

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Differential sensitivity of pancreatic and colon cancer to cyclosporine and α-difluoromethylornithine in vivo. / Saydjari, Rami; Townsend, Courtney; Barranco, Samuel C.; Thompson, James C.

In: Investigational New Drugs, Vol. 6, No. 4, 12.1988, p. 265-272.

Research output: Contribution to journalArticle

@article{8e1348402036421583f07c280e290ee4,
title = "Differential sensitivity of pancreatic and colon cancer to cyclosporine and α-difluoromethylornithine in vivo",
abstract = "We have previously reported that the in vitro growth of MC-26 mouse colon cancer and H2T hamster pancreatic cancer cells are inhibited by cyclosporine (CsA) and α-difluoromethylornithine (DFMO). The present study was designed to investigate the effects of these two drugs on the two experimental tumors (MC-26 and H2T) growing in vivo. Forty-eight male Balb/c mice or Syrian golden hamsters were inoculated with MC-26 (250,000) or H2T (500,000) cells, respectively, and then were randomized into four groups of 12 each: group I was control; group II received CsA; group III received DFMO; group IV received a combination of CsA and DFMO. MC-26 tumors were significantly more sensitive than H2T tumors to the effects of CsA and DFMO. MC-26 tumor growth and tumor weight, as well as the tumor content of DNA, RNA, and protein were all significantly more reduced by CsA and DFMO than were the H2T tumors. Our present study shows that both CsA and DFMO are potent inhibitors of MC-26 colon carcinoma growth in vivo, though DFMO is more than twice as effective as CsA. DFMO also produced greater reductions in the tumor content of DNA, RNA, and protein than did CsA. DFMO significantly decreased the concentrations of polyamines in both H2T and MC-26 tumors; the MC-26 tumors were affected to a greater degree.",
keywords = "colon cancer, cyclosporine, DFMO, pancreatic cancer, polyamines",
author = "Rami Saydjari and Courtney Townsend and Barranco, {Samuel C.} and Thompson, {James C.}",
year = "1988",
month = "12",
doi = "10.1007/BF00173644",
language = "English (US)",
volume = "6",
pages = "265--272",
journal = "Investigational New Drugs",
issn = "0167-6997",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Differential sensitivity of pancreatic and colon cancer to cyclosporine and α-difluoromethylornithine in vivo

AU - Saydjari, Rami

AU - Townsend, Courtney

AU - Barranco, Samuel C.

AU - Thompson, James C.

PY - 1988/12

Y1 - 1988/12

N2 - We have previously reported that the in vitro growth of MC-26 mouse colon cancer and H2T hamster pancreatic cancer cells are inhibited by cyclosporine (CsA) and α-difluoromethylornithine (DFMO). The present study was designed to investigate the effects of these two drugs on the two experimental tumors (MC-26 and H2T) growing in vivo. Forty-eight male Balb/c mice or Syrian golden hamsters were inoculated with MC-26 (250,000) or H2T (500,000) cells, respectively, and then were randomized into four groups of 12 each: group I was control; group II received CsA; group III received DFMO; group IV received a combination of CsA and DFMO. MC-26 tumors were significantly more sensitive than H2T tumors to the effects of CsA and DFMO. MC-26 tumor growth and tumor weight, as well as the tumor content of DNA, RNA, and protein were all significantly more reduced by CsA and DFMO than were the H2T tumors. Our present study shows that both CsA and DFMO are potent inhibitors of MC-26 colon carcinoma growth in vivo, though DFMO is more than twice as effective as CsA. DFMO also produced greater reductions in the tumor content of DNA, RNA, and protein than did CsA. DFMO significantly decreased the concentrations of polyamines in both H2T and MC-26 tumors; the MC-26 tumors were affected to a greater degree.

AB - We have previously reported that the in vitro growth of MC-26 mouse colon cancer and H2T hamster pancreatic cancer cells are inhibited by cyclosporine (CsA) and α-difluoromethylornithine (DFMO). The present study was designed to investigate the effects of these two drugs on the two experimental tumors (MC-26 and H2T) growing in vivo. Forty-eight male Balb/c mice or Syrian golden hamsters were inoculated with MC-26 (250,000) or H2T (500,000) cells, respectively, and then were randomized into four groups of 12 each: group I was control; group II received CsA; group III received DFMO; group IV received a combination of CsA and DFMO. MC-26 tumors were significantly more sensitive than H2T tumors to the effects of CsA and DFMO. MC-26 tumor growth and tumor weight, as well as the tumor content of DNA, RNA, and protein were all significantly more reduced by CsA and DFMO than were the H2T tumors. Our present study shows that both CsA and DFMO are potent inhibitors of MC-26 colon carcinoma growth in vivo, though DFMO is more than twice as effective as CsA. DFMO also produced greater reductions in the tumor content of DNA, RNA, and protein than did CsA. DFMO significantly decreased the concentrations of polyamines in both H2T and MC-26 tumors; the MC-26 tumors were affected to a greater degree.

KW - colon cancer

KW - cyclosporine

KW - DFMO

KW - pancreatic cancer

KW - polyamines

UR - http://www.scopus.com/inward/record.url?scp=0024267658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024267658&partnerID=8YFLogxK

U2 - 10.1007/BF00173644

DO - 10.1007/BF00173644

M3 - Article

VL - 6

SP - 265

EP - 272

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 4

ER -